Accuracy of EEG Slow Wave Activity in Predicting Favourable Outcome in Patients With Hypoxic Brain Injury - A Substudy of STEPCARE Trial

NCT06564675 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-08-28

No results posted yet for this study

Summary

This is an observational substudy embedded in the STEPCARE Trial. The study involves EEG analysis, covered by the ethics approval of STEPCARE Trial. The investigators aim to compare the accuracy of a continuously measured algorithm-based EEG index, C-Trend Index, with retrospective visual analysis of continuous EEG in predicting favorable functional outcome in adult patients treated in intensive care units after out-of-hospital cardiac arrest. The primary hypothesis is that the accuracy of C-Trend Index has at least 10% better accuracy in predicting favorable outcome than the visual analysis of cEEG, when assessed early, 9-12 hours after return of spontaneous circulation (ROSC).

Conditions

  • Out-Of-Hospital Cardiac Arrest

Interventions

DIAGNOSTIC_TEST

C-Trend Index

C-trend-Index is collected blinded from the patients using Brainstatus device. The device shows and collects also cEEG. These are analyzed retrospectively after all study patients have their 6-month follow-up data collected. The intervention does not affect clinical management or decision-making.

Sponsors & Collaborators

  • University of Oulu

    collaborator OTHER
  • Skane University Hospital

    collaborator OTHER
  • Helsinki University Central Hospital

    collaborator OTHER
  • Kuopio University Hospital

    collaborator OTHER
  • Tampere University

    collaborator OTHER
  • Charite University, Berlin, Germany

    collaborator OTHER
  • Oslo University Hospital

    collaborator OTHER
  • Tampere University Hospital

    collaborator OTHER
  • University of Helsinki

    lead OTHER

Principal Investigators

  • Jukka Kortelainen, MD, PhD · University of Oulu

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2026-08-31
Completion
2027-03-03

Countries

  • Finland
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06564675 on ClinicalTrials.gov